Research and development (R&D) costs in cancer are significantly high due to the complexity and extensive resources required to discover, develop, and bring new treatments to market. The process involves multiple stages including basic research, preclinical studies, clinical trials, and regulatory approval. Each of these stages demands significant financial investment, highly specialized personnel, and advanced technology.
